We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Mylan Settles Celebrex Patent Suit, Is Poised to Launch All Strengths This Year
Mylan Settles Celebrex Patent Suit, Is Poised to Launch All Strengths This Year
Generic firm Mylan said Monday that it had reached a settlement with Pfizer to market versions of Celebrex (celecoxib), marking the latest twist in the generic conversion of the blockbuster arthritis pain drug.